MOTCO’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-28,936
| Closed | -$5.32M | – | 606 |
|
|
2025
Q4 | $5.32M | Sell |
28,936
-790
| -3% | -$139K | 0.48% | 68 |
|
|
2025
Q3 | $4.56M | Buy |
29,726
+195
| +0.7% | +$29.5K | 0.42% | 81 |
|
|
2025
Q2 | $4.32M | Sell |
29,531
-211
| -0.7% | -$29.6K | 0.41% | 81 |
|
|
2025
Q1 | $4.37M | Sell |
29,742
-3,555
| -11% | -$514K | 0.46% | 83 |
|
|
2024
Q4 | $4.36M | Buy |
33,297
+269
| +0.8% | +$37.7K | 0.45% | 84 |
|
|
2024
Q3 | $5.15M | Sell |
33,028
-4,189
| -11% | -$676K | 0.51% | 81 |
|
|
2024
Q2 | $5.81M | Sell |
37,217
-1,049
| -3% | -$158K | 0.34% | 88 |
|
|
2024
Q1 | $5.19M | Sell |
38,266
-632
| -2% | -$83.7K | 0.31% | 103 |
|
|
2023
Q4 | $5.24M | Sell |
38,898
-5,727
| -13% | -$744K | 0.34% | 96 |
|
|
2023
Q3 | $6.04M | Sell |
44,625
-4,514
| -9% | -$617K | 0.41% | 85 |
|
|
2023
Q2 | $7.03M | Sell |
49,139
-1,956
| -4% | -$288K | 0.46% | 76 |
|
|
2023
Q1 | $7.09M | Sell |
51,095
-726
| -1% | -$97.7K | 0.48% | 77 |
|
|
2022
Q4 | $7.03M | Sell |
51,821
-2,230
| -4% | -$280K | 0.52% | 74 |
|
|
2022
Q3 | $5.93M | Sell |
54,051
-337
| -0.6% | -$42.8K | 0.47% | 81 |
|
|
2022
Q2 | $7.19M | Sell |
54,388
-6,069
| -10% | -$796K | 0.54% | 54 |
|
|
2022
Q1 | $8.02M | Sell |
60,457
-4,368
| -7% | -$524K | 0.52% | 58 |
|
|
2021
Q4 | $7.55M | Buy |
64,825
+370
| +0.6% | +$43.5K | 0.47% | 83 |
|
|
2021
Q3 | $7.74M | Buy |
64,455
+7,213
| +13% | +$840K | 0.5% | 69 |
|
|
2021
Q2 | $6.86M | Buy |
+57,242
| New | +$6.28M | 0.45% | 84 |
|
|
2020
Q3 | – | Sell |
-433
| Closed | -$46K | – | 709 |
|
|
2020
Q2 | $46K | Hold |
433
| – | – | ﹤0.01% | 327 |
|
|
2020
Q1 | $39K | Hold |
433
| – | – | ﹤0.01% | 320 |
|
|
2019
Q4 | $43K | Sell |
433
-210
| -33% | -$19.8K | ﹤0.01% | 333 |
|
|
2019
Q3 | $57K | Sell |
643
-637
| -50% | -$55.2K | 0.01% | 313 |
|
|
2019
Q2 | $106K | Buy |
1,280
+1,070
| +510% | +$83.9K | 0.01% | 282 |
|
|
2019
Q1 | $17K | Hold |
210
| – | – | ﹤0.01% | 409 |
|
|
2018
Q4 | $16K | Sell |
210
-149
| -42% | -$11.6K | ﹤0.01% | 408 |
|
|
2018
Q3 | $28K | Buy |
+359
| New | +$27.2K | ﹤0.01% | 380 |
|
|
2016
Q4 | – | Sell |
-110
| Closed | -$7K | – | 571 |
|
|
2016
Q3 | $7K | Buy |
+110
| New | +$7.19K | ﹤0.01% | 501 |
|
Other funds holding AZN
IA
VCM
VAM
MOTCO's AZN Position: Q1 2026 in Review
MOTCO sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 28,936 shares — an estimated $5.32M sold.
MOTCO first reported a position in AZN in Q3 2016 and held it in 28 quarters. The position peaked at $8.02M in Q1 2022. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- MOTCO reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- MOTCO sold 28,936 AstraZeneca shares in Q1 2026, an estimated $5.32M.
- MOTCO first reported a position in AstraZeneca in Q3 2016 and held it in 28 quarters.
- MOTCO's AstraZeneca position peaked at $8.02M in Q1 2022.
- 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on MOTCO's 13F filing for Q1 2026, filed 22 Apr 2026.